Renal cell carcinoma: Review of etiology, pathophysiology and risk factors

被引:123
作者
Petejova, Nadezda [1 ,2 ]
Martinek, Arnost [1 ,2 ]
机构
[1] Univ Hosp Ostrava, Dept Internal Med, Ostrava, Czech Republic
[2] Univ Ostrava, Fac Med, Dept Clin Studies, Ostrava, Czech Republic
来源
BIOMEDICAL PAPERS-OLOMOUC | 2016年 / 160卷 / 02期
关键词
hereditary syndromes; nephrectomy; radioactivity; renal cell carcinoma; renal carcinogenesis; uranium toxicity; D-BINDING-PROTEIN; HIGH-DOSE INTERLEUKIN-2; TUMOR-SUPPRESSOR GENE; ATOMIC-BOMB SURVIVORS; CIRCULATING VITAMIN-D; KIDNEY CANCER; HEREDITARY LEIOMYOMATOSIS; MEDULLARY CARCINOMA; RADIATION-EXPOSURE; DNA METHYLATION;
D O I
10.5507/bp.2015.050
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background and Aims. The global incidence of renal cell cancer is increasing annually and the causes are multifactorial. Early diagnosis and successful urological procedures with partial or total nephrectomy can be life-saving. However, only up to 10% of RCC patients present with characteristic clinical symptoms. Over 60% are detected incidentally in routine ultrasound examination. The question of screening and preventive measures greatly depends on the cause of the tumor development. For the latter reason, this review focuses on etiology, pathophysiology and risk factors for renal neoplasm. Methods. A literature search using the databases Medscape, Pubmed, UpToDate and EBSCO from 1945 to 2015. Results and Conclusions. Genetic predisposition/hereditary disorders, obesity, smoking, various nephrotoxic industrial chemicals, drugs and natural/manmade radioactivity all contribute and enviromental risks are a serious concern in terms of prevention and the need to screen populations at risk. Apropos treatment, current oncological research is directed to blocking cancer cell division and inhibiting angiogenesis based on a knowledge of molecular pathways.
引用
收藏
页码:183 / 194
页数:12
相关论文
共 124 条
  • [1] Cytochrome P450 gene polymorphism and cancer
    Agúndez, JAG
    [J]. CURRENT DRUG METABOLISM, 2004, 5 (03) : 211 - 224
  • [2] Mutagenicity of Ochratoxin A and Its Hydroquinone Metabolite in the SupF Gene of the Mutation Reporter Plasmid Ps189
    Akman, Steven A.
    Adams, Marissa
    Case, Doug
    Park, Gyungse
    Manderville, Richard A.
    [J]. TOXINS, 2012, 4 (04) : 267 - 280
  • [3] ALGARD F. THOMAS, 1963, NATL CANCER INST MONOGR, V11, P215
  • [4] Alvaro E, 2011, REV ESP ENFERM DIG, V103, P500, DOI 10.4321/s1130-01082011000900017
  • [5] Exposure assessment for a cohort of workers at a former uranium processing facility
    Anderson, Jeri L.
    Daniels, Robert D.
    Fleming, Donald A.
    Tseng, Chih-yu
    [J]. JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY, 2012, 22 (04) : 324 - 330
  • [6] Serum vitamin D, vitamin D binding protein, and lung cancer survival
    Anic, Gabriella M.
    Weinstein, Stephanie J.
    Mondul, Alison M.
    Mannisto, Satu
    Albanes, Demetrius
    [J]. LUNG CANCER, 2014, 86 (03) : 297 - 303
  • [7] [Anonymous], 2014, J CARCINOG MUTAGEN
  • [8] [Anonymous], 2013, EUR ASS UROLOGY 0301
  • [9] [Anonymous], 2013, GLOBOCAN 2012 ESTIMA
  • [10] [Anonymous], J CLIN ONCOL